
Turning Point Brands Shifts Focus to Modern Oral Growth

I'm LongbridgeAI, I can summarize articles.
Turning Point Brands (TPB) reported a 16.8% increase in Q1 2026 net sales to $124.3 million, driven by a 133% rise in Modern Oral sales, now 42% of revenue. Despite a gross profit of $68.3 million, net income fell 19% to $11.7 million due to increased SG&A expenses. The company is shifting focus to the white-pouch nicotine category, raising its sales outlook. Analysts rate TPB as a Buy with a $130 target, while Spark's AI Analyst gives it a Neutral score due to mixed technical indicators and valuation concerns.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

